EEOC and DOJ Issue Guidance on DEI-related Discrimination📌 (March)

On March 19, 2025, the U.S. Equal Employment Opportunity Commission
(EEOC) and the U.S. Department of Justice (DOJ) issued joint guidance on illegal and discriminatory diversity, equity and inclusion (DEI) practices. The EEOC also issued frequently asked questions (FAQs) regarding DEI-related discrimination. The guidance provides some clarity as to the agencies’ position on what may constitute illegal DEI and offers steps employees may take to report violations.
EEOC and DOJ Issue Guidance on DEI-related Discrimination.docx
⛔IRA Changes to Medicare Part D May Impact Employer Plans⛔ (March)

The Inflation Reduction Act of 2022 (IRA) includes several cost-reduction provisions to Medicare Part D plans that are designed to help beneficiaries but may also impact employer-sponsored health plans.
891339 IRA Changes to Medicare Part D May Impact Employer Plans.docx
❗Employers Should Start Preparing for 2025 RxDC Reporting❗ (March)

Group health plans and health insurance issuers must annually submit detailed information on prescription drug and health care spending to the Centers for Medicare & Medicaid Services {CMS). This reporting is referred to as the “prescription drug data collection” (or “RxDC report”). The next RxDC report is due by Sunday, June 1, 2025, covering data for 2024.
Employers Should Start Preparing for 2025 RxDC Reporting.docx